Crystalline methamphetamine (“ice”) is a growing concern in Australia. There are no approved medications that can be used to treat dependence on this drug. This clinical trial will examine whether mirtazapine, a newly identified treatment agent for methamphetamine use, can be used safely and effectively in routine clinical care to manage methamphetamine dependence in Australia.
Read more here.
Sign-up below to receive the bimonthly Connections email newsletter.
Connections acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures; and to Elders past and present.
UNSW Sydney 2052 Australia
Ph: +61 2 9385 0333
Provider code: 00098G | ABN: 57 195 873 179
